Australian Clinical Labs Dividend
What is Australian Clinical Labs's current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
|Australian Clinical Labs Dividend Yield vs Market|
|Market Bottom 25% (AU)||2.6%|
|Market Top 25% (AU)||6.7%|
|Industry Average (Healthcare)||2.7%|
|Analyst forecast in 3 Years (ACL)||4.3%|
Notable Dividend: ACL's dividend (17.26%) is higher than the bottom 25% of dividend payers in the Australian market (2.56%).
High Dividend: ACL's dividend (17.26%) is in the top 25% of dividend payers in the Australian market (6.67%)
Stability and Growth of Payments
|Month||Dividend Per Share (annual)||Avg. Yield (%)|
Stable Dividend: Too early to tell whether ACL's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if ACL's dividend payments are increasing as they only just started paying a dividend.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (59.9%), ACL's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (40.5%), ACL's dividend payments are well covered by cash flows.